Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com
Clinical Practice Guidelines
The following guidelines are interim and based on the currently limited information we have about the Corona Virus Disease 2019 (COVID-19, formerly referred to as the novel corona virus (nCOV) acute respiratory disease) up to February 26, 2020. The reader is urged to be updated. This is version 2.0 of the guidelines prepared by the Philippine Society of Microbiology and Infectious Diseases (PSMID) and the Philippine Hospital Infection Control Society (PHICS).
Announcements
Attention: Healthcare Practitioners
Here is the updated DOH guidelines on the management and referrals of suspected and confirmed COVID-19 cases under Code Red.
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.